5th Annual West Oncology Conference at Graceland: Advances in the Business of Science of Oncology

 

5th Annual West Oncology Conference at Graceland: Advances in the Business of Science of Oncology
Avatar

Non-Muscle Invasive Bladder Cancer, Pembro Approval and New agents Oportuzumab Monatox and Nadofaragene Firadenovec

By 5th Annual West Oncology Conference at Graceland: Advances in the Business of Science of Oncology FEATURING Brad Somer
By 5th Annual West Oncology Conference at Graceland: Advances in the Business of Science of Oncology FEATURING Brad Somer
187 views
March 13, 2020
0 Comments
Login to view comments. Click here to Login

Featured Video

08:44
Johnson & Johnson

Management and Proactive Care of Adverse Events Associated with Loca…

Feat. J. Sabari, A. Spira

Featured Video

03:38
Lilly Medical Affairs

SERDS: Relevance and Role in Current & Future Treatments for HR+…

Feat. K. Jhaveri
Genitourinary Cancers
23:02

Current Landscape of Molecular Testing in Prostate Cancer: Which Tes…

5th Annual West Oncology Conference at Graceland: Advances in the Business of Science of Oncology

D. Vaena

582 views
07:04

Non-Muscle Invasive Bladder Cancer, Pembro Approval and New agents O…

5th Annual West Oncology Conference at Graceland: Advances in the Business of Science of Oncology

B. Somer

187 views
14:55

Management of Metastatic Urothelial Cancer: Prognostic Value of ctDN…

5th Annual West Oncology Conference at Graceland: Advances in the Business of Science of Oncology

B. Somer

148 views
08:49

Case Study Presentation on Treatment Approach for mUC: What Are the …

5th Annual West Oncology Conference at Graceland: Advances in the Business of Science of Oncology

H. Greene

233 views
09:31

Erdafitinib Treatment of 77 y/o Female With Metastatic Urothelial Ca…

5th Annual West Oncology Conference at Graceland: Advances in the Business of Science of Oncology

H. Greene

136 views